The Company had previously announced 4 clinical sites for new enrollment into the current study.

The Company has now added New York and Los Angeles . In addition, the company. Nearing completion on 4 further sites in New Jersey, Michigan, Texas and Washington As a result the company expects a total of 10 clinical sites for new enrollment into the GBM brain cancer trial have this quarter. This will significantly exceed the company’s projections regarding the expansion of the clinical study in this quarter. In addition, patientslinical sites are expected to commence in the third quarter of this year, a total of 15 locations which. ‘We are delighted that such a strong interest and cooperation from clinical centers in the United States, and is pleased to be ahead of schedule in completing the lengthy and complex institutional processes to these centers operational for enrollment of additional new patients in our ongoing GBM brain cancer trial, ‘said Dr.

courtesy of you, the entire Kaiser Daily Health Policy Report view, search the archives, or sign up for email delivery at Kaiser Daily Health Policy Report strongly supports imperial network. A free service of The Henry J. Releases. Kaiser Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.High-throughput as a human right: A Lesson From UKPsychological On the World Congress on medicine that today has Turin Lord Richard Layard, a professor at LSE ,, data about the UK experience with an improved access to psychological affected area therapy .